Source:http://linkedlifedata.com/resource/pubmed/id/21121962
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2011-1-24
|
pubmed:abstractText |
The large GTPase human guanylate binding protein-1 (GBP-1) is a key mediator of angiostatic effects of inflammation and is induced by interferon (IFN)-? and IFN-? in endothelial cells (ECs). The aim of this study was to investigate whether GBP-1 is a marker of skin lesions in patients with cutaneous lupus erythematosus (CLE). Western blotting revealed that GBP-1 was in vitro induced by IFN-? and -? in primary keratinocytes obtained from healthy controls. Moreover, we found that this protein was expressed by keratinocytes and ECs in primary and ultraviolet (UV)-induced skin lesions from patients with various subtypes of CLE, when compared to non-lesional skin. No GBP-1 expression was noted in skin biopsy specimens 24 or 72 h after UV irradiation prior to lesion formation in patients with CLE or in healthy control specimens with or without UV irradiation. Initial findings suggest that GBP-1 is not expressed in other skin diseases with different inflammatory aetiology, such as atopic dermatitis. We conclude that GBP-1 expression is closely associated with skin lesions in patients with CLE, suggesting a contribution of GBP-1 in the pathogenesis of this disease.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Chemokine CXCL10,
http://linkedlifedata.com/resource/pubmed/chemical/Chemokine CXCL9,
http://linkedlifedata.com/resource/pubmed/chemical/GBP1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/GTP-Binding Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Interferons,
http://linkedlifedata.com/resource/pubmed/chemical/myxovirus resistance proteins
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1600-0625
|
pubmed:author | |
pubmed:copyrightInfo |
© 2011 John Wiley & Sons A/S.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
20
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
102-6
|
pubmed:meshHeading |
pubmed-meshheading:21121962-Adult,
pubmed-meshheading:21121962-Aged,
pubmed-meshheading:21121962-Biopsy,
pubmed-meshheading:21121962-Case-Control Studies,
pubmed-meshheading:21121962-Chemokine CXCL10,
pubmed-meshheading:21121962-Chemokine CXCL9,
pubmed-meshheading:21121962-Female,
pubmed-meshheading:21121962-GTP-Binding Proteins,
pubmed-meshheading:21121962-Humans,
pubmed-meshheading:21121962-Interferons,
pubmed-meshheading:21121962-Keratinocytes,
pubmed-meshheading:21121962-Lupus Erythematosus, Cutaneous,
pubmed-meshheading:21121962-Male,
pubmed-meshheading:21121962-Middle Aged,
pubmed-meshheading:21121962-Skin,
pubmed-meshheading:21121962-Ultraviolet Therapy
|
pubmed:year |
2011
|
pubmed:articleTitle |
Increased expression of guanylate binding protein-1 in lesional skin of patients with cutaneous lupus erythematosus.
|
pubmed:affiliation |
Division of Molecular and Experimental Surgery, University Medical Center Erlangen, Erlangen, Germany. elisabeth.naschberger@uk-erlangen.de
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|